# Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing Loss

> **NCT07472023** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Truway Health, Inc.** · enrollment: 120 (estimated)

## Conditions studied

- Sensorineural Hearing Loss
- Tinnitus
- Acoustic Trauma
- Inner Ear Injury
- Noise-Induced Hearing Loss
- Sudden Hearing Loss
- Vestibular Dysfunction

## Interventions

- **OTHER:** Audiologic Monitoring
- **DRUG:** Investigational Regenerative Pharmacologic Therapy
- **BIOLOGICAL:** Stem Cell Regenerative Therapy
- **COMBINATION_PRODUCT:** Combination Regenerative Therapy

## Key facts

- **NCT ID:** NCT07472023
- **Lead sponsor:** Truway Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-03-08
- **Primary completion:** 2097-03-08
- **Final completion:** 2099-03-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07472023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07472023, "Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing Loss". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07472023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*